Kiniksa (KNSA) CEO gifts 111,794 and 60,000 shares

Kiniksa Pharmaceuticals (KNSA): The Chairman & CEO reported bona fide gifts (Code G) of Class A ordinary shares.

Accepted by SEC EDGAR 11/14/2025 - 04:38 PM EST

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Kiniksa Pharmaceuticals (KNSA): The Chairman & CEO reported bona fide gifts (Code G) of Class A ordinary shares. On 11/12/2025, 111,794 shares were gifted; on 11/13/2025, 60,000 shares were gifted. These entries were at a stated price of $0 per share.

After the transactions, reported holdings were 0 shares direct, and indirect balances included 51,794 shares held by The Anglia 2013 Revocable Trust, 60,000 shares held by The Patel Family Irrevocable Trust of 2025, and 109,795 shares held by The Marina 2016 Irrevocable Trust.

Insider Trade Summary

343,588 shares gifted

Gift 5 txns

Insider Patel Sanj K

Role CHAIRMAN & CEO

Type	Security	Shares	Price	Value
Gift	Class A Ordinary Share	60,000	$0.00	$0.00
Gift	Class A Ordinary Share	60,000	$0.00	$0.00
Gift	Class A Ordinary Share	111,794	$0.00	$0.00
Gift	Class A Ordinary Share	111,794	$0.00	$0.00
holding	Class A Ordinary Share	--	--	--

Holdings After Transaction: Class A Ordinary Share — 0 shares (Direct); Class A Ordinary Share — 51,794 shares (Indirect, Held by The Anglia 2013 Revocable Trust); Class A Ordinary Share — 60,000 shares (Indirect, Held by The Patel Family Irrevocable Trust of 2025); Class A Ordinary Share — 109,795 shares (Indirect, Held by The Marina 2016 Irrevocable Trust)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did KNSA’s insider report on Form 4?

The Chairman & CEO reported bona fide gifts (Code G) of Class A ordinary shares on 11/12/2025 (111,794 shares) and 11/13/2025 (60,000 shares).

What were the gift amounts and dates for KNSA?

111,794 shares were gifted on 11/12/2025 and 60,000 shares were gifted on 11/13/2025, both at a stated price of $0 per share.

How many KNSA shares does the insider hold directly after the transactions?

Direct holdings were reported as 0 shares following the transactions.

What are the indirect KNSA holdings reported after the transactions?

51,794 shares held by The Anglia 2013 Revocable Trust, 60,000 by The Patel Family Irrevocable Trust of 2025, and 109,795 by The Marina 2016 Irrevocable Trust.

What does transaction code G mean on KNSA’s Form 4?

Code G indicates a bona fide gift of the issuer’s securities.

Was a 10b5-1 trading plan indicated for these KNSA transactions?

The excerpt includes the 10b5-1 checkbox language, but no selection is shown in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patel Sanj K

(Last)

(First)

(Middle)

105 PICCADILLY, SECOND FLOOR

(Street)

LONDON

W1J 7NJ

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [ KNSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHAIRMAN & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Ordinary Share	11/12/2025		G		111,794	D	$0	0	D
Class A Ordinary Share	11/12/2025		G		111,794	A	$0	111,794	I	Held by The Anglia 2013 Revocable Trust
Class A Ordinary Share	11/13/2025		G		60,000	D	$0	51,794	I	Held by The Anglia 2013 Revocable Trust
Class A Ordinary Share	11/13/2025		G		60,000	A	$0	60,000	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share								109,795	I	Held by The Marina 2016 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Douglas Barry, Attorney-in-Fact	11/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR